microdosing glp-1 agonists Microdosing: A Medical Perspective on 2025's Most Discussed Wellness Trend Is GLP-1 microdosing for weight

Thiagarajan, R., et al

AOD9604 5mg Modified Human Growth Hormone Fragment (176191) AOD9604 (historically designated Anti-Obesity Drug 9604) is a synthetic 16-amino-acid peptide based on residues 176191 of the C-terminal end of human growth hormone, with an additional N-terminal tyrosine

After complete surgical excision, the local-regional relapse rate is reported to be 10-20%, and 5-year survival rates are clustered around 10-25%, with a reported range of 4.5-48%

Liu B, Zhang J, Yi R, Zhou X, Long X, Pan Y, Zhao X (2019) Preventive effect of Lactobacillus fermentum CQPC08 on 4-nitroquineline-1-oxide induced tongue cancer in C57BL/6 mice

Combining the two can intensify this effect

L-carnitine also helps to move toxins out of cells